Virally mediated cervical cancer in the iatrogenically immunocompromised

Applications for psychoneuroimmunology

Sally E. Jensen, Brandy Lehman, Michael H Antoni, Deidre B. Pereira

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Oncogenic or high-risk (HR) human papillomavirus (HPV) infection is implicated in the pathogenesis of a number of cancers, including cervical cancer. HPV infected individuals who are immunocompromised secondary to acquired (e.g., human immunodeficiency virus [HIV]) or iatrogenic (e.g., systemic lupus erythematosus [SLE] patients and organ and hematopoeitic stem cell transplant recipients undergoing immunosuppressive therapy) immune deficiency are particularly at risk for HPV-initiated cervical neoplasia and cancer. Psychoneuroimmunologic (PNI) research has demonstrated that psychosocial factors such as stress, pessimism, and sleep quality may play a role in the promotion of HPV-mediated cervical neoplasia in HIV-positive women. However, no research to our knowledge has examined PNI mechanisms of HPV-mediated cervical neoplasia and cancer in women who are undergoing iatrogenic immunosuppressive therapy for the treatment of autoimmune disease or the prevention of graft-rejection. This article reviews the PNI mechanisms that may underlie the promotion of HPV-mediated cervical neoplasia and applies this model to HPV-infected women who are iatrogenically immunosuppressed, an understudied population at-risk for cervical cancer. Female transplant recipients, one such group, may provide a unique paradigm in which to explore further PNI mechanisms of HPV-mediated cervical neoplasia.

Original languageEnglish
Pages (from-to)758-766
Number of pages9
JournalBrain, Behavior, and Immunity
Volume21
Issue number6
DOIs
StatePublished - Aug 1 2007

Fingerprint

Psychoneuroimmunology
Uterine Cervical Neoplasms
Neoplasms
Immunosuppressive Agents
HIV
Papillomavirus Infections
Graft Rejection
Research
Systemic Lupus Erythematosus
Autoimmune Diseases
Sleep
Stem Cells
Therapeutics
Psychology
Transplants

Keywords

  • Cervical cancer
  • Human papillomavirus (HPV)
  • Psychoneuroimmunology (PNI)
  • Renal transplant

ASJC Scopus subject areas

  • Immunology
  • Behavioral Neuroscience
  • Endocrine and Autonomic Systems

Cite this

Virally mediated cervical cancer in the iatrogenically immunocompromised : Applications for psychoneuroimmunology. / Jensen, Sally E.; Lehman, Brandy; Antoni, Michael H; Pereira, Deidre B.

In: Brain, Behavior, and Immunity, Vol. 21, No. 6, 01.08.2007, p. 758-766.

Research output: Contribution to journalArticle

@article{bfc6ce7454fb4b8ba13bc135e6988730,
title = "Virally mediated cervical cancer in the iatrogenically immunocompromised: Applications for psychoneuroimmunology",
abstract = "Oncogenic or high-risk (HR) human papillomavirus (HPV) infection is implicated in the pathogenesis of a number of cancers, including cervical cancer. HPV infected individuals who are immunocompromised secondary to acquired (e.g., human immunodeficiency virus [HIV]) or iatrogenic (e.g., systemic lupus erythematosus [SLE] patients and organ and hematopoeitic stem cell transplant recipients undergoing immunosuppressive therapy) immune deficiency are particularly at risk for HPV-initiated cervical neoplasia and cancer. Psychoneuroimmunologic (PNI) research has demonstrated that psychosocial factors such as stress, pessimism, and sleep quality may play a role in the promotion of HPV-mediated cervical neoplasia in HIV-positive women. However, no research to our knowledge has examined PNI mechanisms of HPV-mediated cervical neoplasia and cancer in women who are undergoing iatrogenic immunosuppressive therapy for the treatment of autoimmune disease or the prevention of graft-rejection. This article reviews the PNI mechanisms that may underlie the promotion of HPV-mediated cervical neoplasia and applies this model to HPV-infected women who are iatrogenically immunosuppressed, an understudied population at-risk for cervical cancer. Female transplant recipients, one such group, may provide a unique paradigm in which to explore further PNI mechanisms of HPV-mediated cervical neoplasia.",
keywords = "Cervical cancer, Human papillomavirus (HPV), Psychoneuroimmunology (PNI), Renal transplant",
author = "Jensen, {Sally E.} and Brandy Lehman and Antoni, {Michael H} and Pereira, {Deidre B.}",
year = "2007",
month = "8",
day = "1",
doi = "10.1016/j.bbi.2007.01.003",
language = "English",
volume = "21",
pages = "758--766",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Virally mediated cervical cancer in the iatrogenically immunocompromised

T2 - Applications for psychoneuroimmunology

AU - Jensen, Sally E.

AU - Lehman, Brandy

AU - Antoni, Michael H

AU - Pereira, Deidre B.

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Oncogenic or high-risk (HR) human papillomavirus (HPV) infection is implicated in the pathogenesis of a number of cancers, including cervical cancer. HPV infected individuals who are immunocompromised secondary to acquired (e.g., human immunodeficiency virus [HIV]) or iatrogenic (e.g., systemic lupus erythematosus [SLE] patients and organ and hematopoeitic stem cell transplant recipients undergoing immunosuppressive therapy) immune deficiency are particularly at risk for HPV-initiated cervical neoplasia and cancer. Psychoneuroimmunologic (PNI) research has demonstrated that psychosocial factors such as stress, pessimism, and sleep quality may play a role in the promotion of HPV-mediated cervical neoplasia in HIV-positive women. However, no research to our knowledge has examined PNI mechanisms of HPV-mediated cervical neoplasia and cancer in women who are undergoing iatrogenic immunosuppressive therapy for the treatment of autoimmune disease or the prevention of graft-rejection. This article reviews the PNI mechanisms that may underlie the promotion of HPV-mediated cervical neoplasia and applies this model to HPV-infected women who are iatrogenically immunosuppressed, an understudied population at-risk for cervical cancer. Female transplant recipients, one such group, may provide a unique paradigm in which to explore further PNI mechanisms of HPV-mediated cervical neoplasia.

AB - Oncogenic or high-risk (HR) human papillomavirus (HPV) infection is implicated in the pathogenesis of a number of cancers, including cervical cancer. HPV infected individuals who are immunocompromised secondary to acquired (e.g., human immunodeficiency virus [HIV]) or iatrogenic (e.g., systemic lupus erythematosus [SLE] patients and organ and hematopoeitic stem cell transplant recipients undergoing immunosuppressive therapy) immune deficiency are particularly at risk for HPV-initiated cervical neoplasia and cancer. Psychoneuroimmunologic (PNI) research has demonstrated that psychosocial factors such as stress, pessimism, and sleep quality may play a role in the promotion of HPV-mediated cervical neoplasia in HIV-positive women. However, no research to our knowledge has examined PNI mechanisms of HPV-mediated cervical neoplasia and cancer in women who are undergoing iatrogenic immunosuppressive therapy for the treatment of autoimmune disease or the prevention of graft-rejection. This article reviews the PNI mechanisms that may underlie the promotion of HPV-mediated cervical neoplasia and applies this model to HPV-infected women who are iatrogenically immunosuppressed, an understudied population at-risk for cervical cancer. Female transplant recipients, one such group, may provide a unique paradigm in which to explore further PNI mechanisms of HPV-mediated cervical neoplasia.

KW - Cervical cancer

KW - Human papillomavirus (HPV)

KW - Psychoneuroimmunology (PNI)

KW - Renal transplant

UR - http://www.scopus.com/inward/record.url?scp=34347273404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347273404&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2007.01.003

DO - 10.1016/j.bbi.2007.01.003

M3 - Article

VL - 21

SP - 758

EP - 766

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

IS - 6

ER -